Weikai Xiao
- Oncology top 5%
- Cancer Research top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Hepatology top 5%
- Co-authors
- Yutian ZouShaoquan ZhengBaogang PengAnli YangShaoqiang LiShunjun FuHailin TangLi‐Jian Liang
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Cancer Genomics and Diagnostics (7 papers)Breast Cancer Treatment Studies (6 papers)
- Cited by
- Cancer ResearchHepatologyOncology
- Partner nations
- ChinaUnited States
In The Last Decade
Weikai Xiao
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 82
- Oncology 477
- Cancer Research 473
- Molecular Biology 425
- Pulmonary and Respiratory Medicine 265
- Hepatology 213
Countries citing papers authored by Weikai Xiao
This map shows the geographic impact of Weikai Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weikai Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weikai Xiao more than expected).
Fields of papers citing papers by Weikai Xiao
This network shows the impact of papers produced by Weikai Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weikai Xiao. The network helps show where Weikai Xiao may publish in the future.
Co-authorship network of co-authors of Weikai Xiao
This figure shows the co-authorship network connecting the top 25 collaborators of Weikai Xiao. A scholar is included among the top collaborators of Weikai Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weikai Xiao. Weikai Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 42 | |
| 3 | 9 | |
| 4 | 5 | |
| 5 | 18 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | 28 | |
| 9 | 9 | |
| 10 | 121 | |
| 11 | 67 | |
| 12 | 5 | |
| 13 | 36 | |
| 14 | 33 | |
| 15 | 1 | |
| 16 | 189 | |
| 17 | 39 | |
| 18 | 72 | |
| 19 | 28 | |
| 20 | Expression of Claudins in the Normal Adult Human Retinas | 1 |
About Weikai Xiao
Weikai Xiao is a scholar working on Cancer Research, Hepatology and Oncology, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Genomics and Diagnostics (7 papers) and Breast Cancer Treatment Studies (6 papers). The work is most often cited by research in Cancer Research (473 citations), Hepatology (213 citations) and Oncology (477 citations). Weikai Xiao has collaborated with scholars based in China and United States. Frequent co-authors include Yutian Zou, Shaoquan Zheng, Baogang Peng, Anli Yang, Shaoqiang Li, Shunjun Fu, Hailin Tang, Li‐Jian Liang, Xiaoming Xie and Dong Chen. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.